Skip to content

Sbi Lateral Rhead Implant

by Small Bone Innovations, Inc.

510(k) K062898

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

14 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK062898 Date13 Nov 2006ClearedStatusActive

Recalls

14 recalls · FDA

  • 13 recalls, same reason

    • Terminated Z-2671-2018 FDA Class II initiated 24 Oct 2017
    • Terminated Z-2665-2018 FDA Class II initiated 24 Oct 2017
    • Terminated Z-2673-2018 FDA Class II initiated 24 Oct 2017
    • Terminated Z-2675-2018 FDA Class II initiated 24 Oct 2017
    • Terminated Z-2672-2018 FDA Class II initiated 24 Oct 2017
    • Terminated Z-2674-2018 FDA Class II initiated 24 Oct 2017
    • Terminated Z-2664-2018 FDA Class II initiated 24 Oct 2017
    • Terminated Z-2667-2018 FDA Class II initiated 24 Oct 2017
    • Terminated Z-2663-2018 FDA Class II initiated 24 Oct 2017
    • Terminated Z-2669-2018 FDA Class II initiated 24 Oct 2017
    • Terminated Z-2668-2018 FDA Class II initiated 24 Oct 2017
    • Terminated Z-2670-2018 FDA Class II initiated 24 Oct 2017
    • Terminated Z-2666-2018 FDA Class II initiated 24 Oct 2017

    Revision rate identified as higher than other proximal radial head replacement devices based on literature review. Product may not perform at expected level post-surgery.

    • Terminated Z-0098-2014 FDA Class II initiated 6 Sep 2013

    The recall was initiated due to an increased risk of implants breaching the sterile pouches inside the shrink-wrapped box.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KWI
Device Class
Class II
Regulation
21 CFR Part 888.3170
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Other devices from Small Bone Innovations, Inc.

See all devices from Small Bone Innovations, Inc. →